230 likes | 384 Views
Liquid Biopsy Tests are emerging as a viable alternative to traditional methods for cancer screening. A liquid biopsy is a new type of blood test that has the potential to transform cancer treatment.
E N D
Table of Contents 1. Executive Summary 2. United States - Liquid Biopsy Potential Market (2015 – 2020) 2.1 United States - Liquid Biopsy Potential Market2.2 United States - Liquid Biopsy Screening Potential Market2.3 United States - Liquid Biopsy Treatment Monitoring Potential Market 3. United States - Liquid Biopsy Potential Test Volume (2015 – 2020)
Continue (www.renub.com) 3.1 United States - Liquid Biopsy Potential Test Volume3.2 United States - Liquid Biopsy Potential Screening Test Volume3.3 United States - Liquid Biopsy Potential Treatment Monitoring Test Volume 4. United States - Liquid Biopsy Potential Market Share (2015 – 2020) 4.1 United States - Liquid Biopsy Potential Market Share by Method
Continue (www.renub.com) 4.2 United States - Liquid Biopsy Screening Potential Market Share by Cancer Types4.3 United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types 5. United States - Liquid Biopsy Potential Market & Test Volume by Cancer Types (2015 – 2020) 5.1 United States - Liquid Biopsy Lung Cancer Potential Market & Test Volume5.1.1 United States - Liquid Biopsy Lung Cancer Potential Market
Continue (www.renub.com) 5.1.2 United States - Liquid Biopsy Lung Cancer Potential Test Volume 5.2 United States - Liquid Biopsy Breast Cancer Potential Market & Test Volume5.2.1 United States - Liquid Biopsy Breast Cancer Potential Market5.2.2 United States - Liquid Biopsy Breast Cancer Potential Test Volume 5.3 United States - Liquid Biopsy Colorectal Cancer Potential Market & Test Volume
Continue (www.renub.com) 5.3.1 United States - Liquid Biopsy Colorectal Cancer Potential Market5.3.2 United States - Liquid Biopsy Colorectal Cancer Potential Test Volume 5.4 United States - Liquid Biopsy Prostate Cancer Potential Market & Test Volume5.4.1 United States - Liquid Biopsy Prostate Cancer Potential Market5.4.2 United States - Liquid Biopsy Prostate Cancer Potential Test Volume
Continue (www.renub.com) 5.5 United States - Liquid Biopsy Liver Cancer Potential Market & Test Volume 5.5.1United States - Liquid Biopsy Liver Cancer Potential Market 5.5.2 United States - Liquid Biopsy Liver Cancer Potential Test Volume 6. United States - Liquid Biopsy Screening Potential Market & Test Volume by Cancer Types (2015 – 2020) 6.1 United States - Liquid Biopsy Lung Cancer Screening Potential Market & Test Volume
Continue (www.renub.com) 6.1.1 United States - Liquid Biopsy Lung Cancer Screening Potential Market 6.1.2United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume 6.2 United States - Liquid Biopsy Breast Cancer Screening Potential Market & Test Volume 6.2.1United States - Liquid Biopsy Breast Cancer Screening Potential Market
Continue (www.renub.com) 6.2.2 United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume 6.3 United States - Liquid Biopsy Colorectal Cancer Screening Potential Market & Test Volume 6.3.1United States - Liquid Biopsy Colorectal Cancer Screening Potential Market 6.3.2United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume
Continue (www.renub.com) 6.4 United States - Liquid Biopsy Prostate Cancer Screening Potential Market & Test Volume 6.4.1 United States - Liquid Biopsy Prostate Cancer Screening Potential Market 6.4.2 United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume 6.5 United States - Liquid Biopsy Liver Cancer Screening Potential Market & Test Volume
Continue (www.renub.com) 6.5.1 United States - Liquid Biopsy Liver Cancer Screening Potential Market 6.5.2United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume 7. United States - Liquid Biopsy Treatment Monitoring Potential Market & Test Volume by Cancer Types (2015 – 2020) 7.1 United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market & Test Volume
Continue (www.renub.com) 7.1.1 United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market 7.1.2United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume 7.2 United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market & Test Volume 7.2.1United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market
Continue (www.renub.com) 7.2.2 United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume 7.3 United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market & Test Volume 7.3.1United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market 7.3.2United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test Volume
Continue (www.renub.com) 7.4 United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market & Test Volume 7.4.1United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market 7.4.2United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume 7.5 United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market & Test Volume
Continue (www.renub.com) 7.5.1United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market 7.5.2United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume 7.6 United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market & Test Volume 7.6.1 United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market
Continue (www.renub.com) 7.6.2 United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume 8. Liquid Biopsy Market – Recent Development 9. Liquid Biopsy Market – Major Deals Analysis 10. Liquid Biopsy Market – Driving Factors 10.1 Real-Time Evaluation, Convenient and Accuracy 10.2 Increasing Demand for Minimally-Invasive Biopsy Techniques
Continue (www.renub.com) 10.3 Technical Advancement & Personalized Therapies 11. Liquid Biopsy Market – Challenges 11.1Barriers for Liquid Biopsies 11.1.1Comparatively Low Concentration of Molecular Biomarkers in Body Fluids 11.1.2Low Concentration of Target DNA in A Plasma Sample 11.1.3Proper Handling and Storage of the Samples Critical
Order Form Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +1-678-302-0700 (USA) +91-120-421-9822 (India), ,+91-120-424-9780 or mail to info@renub.com
Format Report Title:United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020 For More Details: http://www.renub.com/united-states-liquid-biopsy-potential-testing-market-and-volume-analysis-to-2020-515-p.php
For ordering this report: Three easy ways to place your order Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/united-states-liquid-biopsy-potential-testing-market-and-volume-analysis-to-2020-515-p.php
Bank Details Account Name:Renub Research A/C No.:109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code:IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India
Contact Information First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:
Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor, C-86, Sector-10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780 For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)